Home
Insitro

Insitro Market Share Analysis for March 2026

At insitro, our mission is to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.

Science and Education > Biology

Domaininsitro.com

Year Founded2018

Employees201 - 500

Annual Revenue$15M - $25M

Insitro

Insitro (including company regionals)

insitro.com

See more website traffic and engagement information

Insitro Revenue up to March 2026 is 15M - 25M

revenue generated by Insitro top domains

Insitro top domains revenue over 3 years

Revenue for Insitro top domains

insitro.com15M - 25M

See more with Sales Intelligence

Total visits to Insitro's top domains

Understand Insitro market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

insitro.com17K

See more with Sales Intelligence

Avg. visit duration in Insitro's top domains

Analyze Insitro engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

insitro.com00:00:49

See more with Sales Intelligence

Avg. pageviews on Insitro's top domains

See how Insitro keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

insitro.com1.91

See more with Sales Intelligence

Insitro top competitors by domain

Top similar sites in March 2026, ranked by their affinity

unlearn.aiCompany NameUnlearn.ai, Inc.Employees51 - 200HQUnited States, California, San FranciscoAnnual revenue$2M - $5MTotal visits23KJobs and Career > Human Resources

Top technologies used by Insitro

These are the website technologies, by industry, used by Insitro top domains

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

9

See all

News & Signals from Insitro

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInsitro, Inc. partnered with Bristol-Myers Squibb Co on Mar 23rd '26.SOUTH SAN FRANCISCO, Calif. - insitro, the AI therapeutics company built on causal biology, today announced the expansion of its strategic collaboration with Bristol Myers Squibb (NYSE: BMY) to advance a broadened portfolio of therapeutic programs for amyotrophic lateral sclerosis (ALS).